Mouse clinical trials of pancreatic cancer: Integration of PDX models with genomics to improve patient outcomes to chemotherapeutics

被引：2
|
作者：
Davies, A. [1 ]
Hidalgo, M. [2 ]
Stebbing, J. [3 ]
Ciznadija, D. [4 ]
Katz, A. [4 ]
Sidransky, D. [5 ]
机构：
[1] Champ Oncol, Med Affairs, Hackensack, NJ USA
[2] Hosp Madrid Norte San Chinarro, Ctr Integral Oncol Clara Campal, CIOCC, Madrid, Spain
[3] Imperial Coll London, Hammersmith Hosp, Surg & Canc, London, England
[4] Champ Oncol, Translat Oncol, Hackensack, NJ USA
[5] Johns Hopkins Univ Hosp, Med, Baltimore, MD 21287 USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw392.4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1522P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Roadmap for Connecting Cancer Rehabilitation With Survivorship to Improve Patient Outcomes and Clinical Efficiency
    Alfano, Catherine M.
    Pugh, Terrence M.
    Tortorella, Brooke
    Jacob, Regina A.
    Mitchell, Charles H.
    Raj, Vishwa S.
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2024, 103 (3S) : S10 - S15
  • [42] On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models
    Savel, Helene
    Barbier, Sandrine
    Proust-Lima, Cecile
    Rondeau, Virginie
    Thiebaut, Rodolphe
    Meyer-Losic, Florence
    Richert, Laura
    CANCER RESEARCH COMMUNICATIONS, 2023, 3 (01): : 140 - 147
  • [43] Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute - Sponsored clinical trials networks
    Sloan, Jeff A.
    Berk, Lawrence
    Roscoe, Joseph
    Fisch, Michael J.
    Shaw, Edward G.
    Wyatt, Gwen
    Morrow, Gary R.
    Dueck, Amylou C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (32) : 5070 - 5077
  • [44] How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia?
    Clapcote, Steven J.
    DISEASE MODELS & MECHANISMS, 2022, 15 (11)
  • [45] Patient-derived xenograft (PDX) models from metastatic castration-resistant prostate cancer (mCRPC) patients reflect clinical disease and therapeutic outcomes
    Ciznadija, D.
    Kipp, P.
    Kohli, M.
    Tati, S.
    Mancini, M.
    Davies, A.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E85 - E85
  • [46] Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials
    Rinninella, Emanuele
    Fagotti, Anna
    Cintoni, Marco
    Raoul, Pauline
    Scaletta, Giuseppe
    Quagliozzi, Lorena
    Miggiano, Giacinto Abele Donato
    Scambia, Giovanni
    Gasbarrini, Antonio
    Mele, Maria Cristina
    NUTRIENTS, 2019, 11 (06)
  • [47] NUTRITIONAL INTERVENTIONS TO IMPROVE CLINICAL OUTCOMES IN OVARIAN CANCER: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
    Marchetti, C.
    Mele, M. C.
    Rinninella, E.
    Cintoni, M.
    Raoul, P.
    Scaletta, G.
    Gasbarrini, A.
    Scambia, G.
    Fagotti, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A51 - A51
  • [48] Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?
    Bruner, Deborah Watkins
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5345 - 5347
  • [49] Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials-Response
    Kluetz, Paul G.
    Papadopoulos, Elektra J.
    Johnson, Laura Lee
    Donoghue, Martha
    Kwitkowski, Virginia E.
    Chen, Wen-Hung
    Sridhara, Rajeshwari
    Farrell, Ann T.
    Keegan, Patricia
    Kim, Geoffrey
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2016, 22 (22) : 5618 - 5618
  • [50] EVALUATING PATIENT REPORTED OUTCOMES COMMONLY USED IN CURRENT LUNG CANCER CLINICAL TRIALS
    Grimes, R.
    Grant, L.
    Kaur, S.
    Spencer, H.
    Brookes, B.
    Bennett, B.
    VALUE IN HEALTH, 2017, 20 (09) : A764 - A764
12345